Question 1

Do analysts rate CCAP or CGBD?

Accepted Answer

Crescent Capital BDC currently has a consensus price target of $13.90, indicating a potential upside of 26.82%. Carlyle Secured Lending has a consensus price target of $12.50, indicating a potential upside of 19.27%. Given Crescent Capital BDC's higher possible upside, equities research analysts plainly believe Crescent Capital BDC is more favorable than Carlyle Secured Lending. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Carlyle Secured Lending 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43

Question 2

Is CCAP or CGBD a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. Carlyle Secured Lending pays an annual dividend of $1.40 per share and has a dividend yield of 13.4%. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Carlyle Secured Lending pays out 197.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Carlyle Secured Lending is clearly the better dividend stock, given its higher yield and lower payout ratio.

Question 3

Which has preferable earnings and valuation, CCAP or CGBD?

Accepted Answer

Carlyle Secured Lending has higher revenue and earnings than Crescent Capital BDC. Carlyle Secured Lending is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.41 $34.51M $0.41 26.73 Carlyle Secured Lending $255.57M 2.85 $69.97M $0.71 14.76

Question 4

Do institutionals & insiders hold more shares of CCAP or CGBD?

Accepted Answer

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 24.5% of Carlyle Secured Lending shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by company insiders. Comparatively, 0.4% of Carlyle Secured Lending shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Question 5

Is CCAP or CGBD more profitable?

Accepted Answer

Carlyle Secured Lending has a net margin of 19.52% compared to Crescent Capital BDC's net margin of 9.26%. Crescent Capital BDC's return on equity of 9.34% beat Carlyle Secured Lending's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC 9.26% 9.34% 4.04% Carlyle Secured Lending 19.52% 8.99% 4.01%

Question 6

Which has more risk & volatility, CCAP or CGBD?

Accepted Answer

Crescent Capital BDC has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Carlyle Secured Lending has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Question 7

Does the media prefer CCAP or CGBD?

Accepted Answer

In the previous week, Crescent Capital BDC and Crescent Capital BDC both had 2 articles in the media. Carlyle Secured Lending's average media sentiment score of 1.90 beat Crescent Capital BDC's score of 0.14 indicating that Carlyle Secured Lending is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Carlyle Secured Lending 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Question 8

Do analysts prefer CCAP or MFIC?

Accepted Answer

Crescent Capital BDC currently has a consensus target price of $13.90, suggesting a potential upside of 26.82%. MidCap Financial Investment has a consensus target price of $11.46, suggesting a potential upside of 17.34%. Given Crescent Capital BDC's higher probable upside, equities research analysts plainly believe Crescent Capital BDC is more favorable than MidCap Financial Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 MidCap Financial Investment 0 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.22

Question 9

Is CCAP or MFIC a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 12.7%. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. MidCap Financial Investment pays out 3,100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years.

Question 10

Which has better earnings and valuation, CCAP or MFIC?

Accepted Answer

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.41 $34.51M $0.41 26.73 MidCap Financial Investment $320.88M 2.51 $63.17M $0.04 244.25

Question 11

Do institutionals and insiders believe in CCAP or MFIC?

Accepted Answer

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.5% of MidCap Financial Investment shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by insiders. Comparatively, 0.9% of MidCap Financial Investment shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Question 12

Is CCAP or MFIC more profitable?

Accepted Answer

Crescent Capital BDC has a net margin of 9.26% compared to MidCap Financial Investment's net margin of 1.90%. MidCap Financial Investment's return on equity of 10.86% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC 9.26% 9.34% 4.04% MidCap Financial Investment 1.90% 10.86% 4.31%

Question 13

Which has more volatility and risk, CCAP or MFIC?

Accepted Answer

Crescent Capital BDC has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, MidCap Financial Investment has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

Question 14

Does the media refer more to CCAP or MFIC?

Accepted Answer

In the previous week, Crescent Capital BDC and Crescent Capital BDC both had 2 articles in the media. MidCap Financial Investment's average media sentiment score of 0.47 beat Crescent Capital BDC's score of 0.14 indicating that MidCap Financial Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MidCap Financial Investment 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Question 15

Do analysts prefer SLRC or CCAP?

Accepted Answer

SLR Investment currently has a consensus target price of $14.10, indicating a potential upside of 8.96%. Crescent Capital BDC has a consensus target price of $13.90, indicating a potential upside of 26.82%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts clearly believe Crescent Capital BDC is more favorable than SLR Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SLR Investment 3 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.86 Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Question 16

Is SLRC or CCAP a better dividend stock?

Accepted Answer

SLR Investment pays an annual dividend of $1.24 per share and has a dividend yield of 9.6%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. SLR Investment pays out 75.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 17

Which has higher earnings and valuation, SLRC or CCAP?

Accepted Answer

SLR Investment has higher revenue and earnings than Crescent Capital BDC. SLR Investment is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SLR Investment $218.54M 3.23 $92.54M $1.64 7.89 Crescent Capital BDC $167.29M 2.41 $34.51M $0.41 26.73

Question 18

Do institutionals and insiders believe in SLRC or CCAP?

Accepted Answer

35.3% of SLR Investment shares are owned by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are owned by institutional investors. 8.8% of SLR Investment shares are owned by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Question 19

Is SLRC or CCAP more profitable?

Accepted Answer

SLR Investment has a net margin of 41.81% compared to Crescent Capital BDC's net margin of 9.26%. Crescent Capital BDC's return on equity of 9.34% beat SLR Investment's return on equity. Company Net Margins Return on Equity Return on Assets SLR Investment 41.81% 8.33% 3.25% Crescent Capital BDC 9.26% 9.34% 4.04%

Question 20

Which has more volatility and risk, SLRC or CCAP?

Accepted Answer

SLR Investment has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

Question 21

Does the media prefer SLRC or CCAP?

Accepted Answer

In the previous week, Crescent Capital BDC had 1 more articles in the media than SLR Investment. MarketBeat recorded 2 mentions for Crescent Capital BDC and 1 mentions for SLR Investment. SLR Investment's average media sentiment score of 1.89 beat Crescent Capital BDC's score of 0.14 indicating that SLR Investment is being referred to more favorably in the media. Company Overall Sentiment SLR Investment Very Positive Crescent Capital BDC Neutral

Question 22

Do analysts recommend CCAP or BCSF?

Accepted Answer

Crescent Capital BDC currently has a consensus price target of $13.90, indicating a potential upside of 26.82%. Bain Capital Specialty Finance has a consensus price target of $14.00, indicating a potential upside of 10.52%. Given Crescent Capital BDC's higher probable upside, research analysts plainly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Bain Capital Specialty Finance 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Question 23

Is CCAP or BCSF a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 13.3%. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance pays out 147.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years and Bain Capital Specialty Finance has raised its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 24

Which has preferable earnings & valuation, CCAP or BCSF?

Accepted Answer

Bain Capital Specialty Finance has higher revenue and earnings than Crescent Capital BDC. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.41 $34.51M $0.41 26.73 Bain Capital Specialty Finance $273.24M 3.01 $98.76M $1.14 11.11

Question 25

Do insiders and institutionals believe in CCAP or BCSF?

Accepted Answer

49.5% of Crescent Capital BDC shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Question 26

Is CCAP or BCSF more profitable?

Accepted Answer

Bain Capital Specialty Finance has a net margin of 27.00% compared to Crescent Capital BDC's net margin of 9.26%. Bain Capital Specialty Finance's return on equity of 10.44% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC 9.26% 9.34% 4.04% Bain Capital Specialty Finance 27.00% 10.44% 4.35%

Question 27

Which has more volatility & risk, CCAP or BCSF?

Accepted Answer

Crescent Capital BDC has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Bain Capital Specialty Finance has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

Question 28

Does the media refer more to CCAP or BCSF?

Accepted Answer

In the previous week, Crescent Capital BDC had 2 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 2 mentions for Crescent Capital BDC and 0 mentions for Bain Capital Specialty Finance. Crescent Capital BDC's average media sentiment score of 0.14 beat Bain Capital Specialty Finance's score of 0.00 indicating that Crescent Capital BDC is being referred to more favorably in the media. Company Overall Sentiment Crescent Capital BDC Neutral Bain Capital Specialty Finance Neutral

Question 29

Do analysts prefer CCAP or GSBD?

Accepted Answer

Crescent Capital BDC currently has a consensus price target of $13.90, suggesting a potential upside of 26.82%. Goldman Sachs BDC has a consensus price target of $8.50, suggesting a potential downside of 3.68%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, equities research analysts plainly believe Crescent Capital BDC is more favorable than Goldman Sachs BDC. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Goldman Sachs BDC 4 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.43

Question 30

Is CCAP or GSBD a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. Goldman Sachs BDC pays an annual dividend of $1.28 per share and has a dividend yield of 14.5%. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Goldman Sachs BDC pays out 196.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Goldman Sachs BDC is clearly the better dividend stock, given its higher yield and lower payout ratio.

Question 31

Which has preferable valuation & earnings, CCAP or GSBD?

Accepted Answer

Goldman Sachs BDC has higher revenue and earnings than Crescent Capital BDC. Goldman Sachs BDC is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.41 $34.51M $0.41 26.73 Goldman Sachs BDC $365.57M 2.72 $119.27M $0.65 13.58

Question 32

Do institutionals & insiders believe in CCAP or GSBD?

Accepted Answer

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.7% of Goldman Sachs BDC shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by company insiders. Comparatively, 0.1% of Goldman Sachs BDC shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Question 33

Is CCAP or GSBD more profitable?

Accepted Answer

Goldman Sachs BDC has a net margin of 21.32% compared to Crescent Capital BDC's net margin of 9.26%. Goldman Sachs BDC's return on equity of 10.94% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC 9.26% 9.34% 4.04% Goldman Sachs BDC 21.32% 10.94% 4.66%

Question 34

Which has more volatility and risk, CCAP or GSBD?

Accepted Answer

Crescent Capital BDC has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Goldman Sachs BDC has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

Question 35

Does the media favor CCAP or GSBD?

Accepted Answer

In the previous week, Goldman Sachs BDC had 5 more articles in the media than Crescent Capital BDC. MarketBeat recorded 7 mentions for Goldman Sachs BDC and 2 mentions for Crescent Capital BDC. Goldman Sachs BDC's average media sentiment score of 0.19 beat Crescent Capital BDC's score of 0.14 indicating that Goldman Sachs BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Goldman Sachs BDC 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Metric	Crescent Capital BDC	FIN Industry	Finance Sector	NASDAQ Exchange
Market Cap	$408.62M	$1.30B	$14.26B	$12.61B
Dividend Yield	12.26%	13.16%	5.70%	8.01%
P/E Ratio	26.73	11.26	20.48	24.26
Price / Sales	2.41	13.85	44.54	94.41
Price / Cash	6.46	6.90	19.34	49.36
Price / Book	0.57	0.76	2.25	6.29
Net Income	$34.51M	$121.13M	$1.13B	$330.66M
7 Day Performance	-0.36%	-0.93%	-0.76%	-2.41%
1 Month Performance	-2.66%	-3.05%	0.61%	-0.64%
1 Year Performance	-25.64%	-24.48%	12.27%	20.09%

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCAP Crescent Capital BDC	4.71 of 5 stars	$10.96 -1.2%	$13.90 +26.8%	-24.8%	$408.62M	$167.29M	26.73	N/A
CGBD Carlyle Secured Lending	3.735 of 5 stars	$10.39 -1.3%	$12.50 +20.3%	-25.7%	$722.11M	$255.57M	14.63	N/A	Positive News
MFIC MidCap Financial Investment	2.203 of 5 stars	$9.98 -0.1%	$11.46 +14.9%	-25.0%	$822.08M	$22.82M	249.56	N/A
SLRC SLR Investment	4.2001 of 5 stars	$12.60 -1.9%	$14.10 +11.9%	-21.0%	$687.46M	$218.54M	7.68	N/A	Positive News
BCSF Bain Capital Specialty Finance	2.4851 of 5 stars	$12.68 +0.7%	$14.00 +10.5%	-16.9%	$822.23M	$273.24M	11.12	1,000

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, SLRC, BCSF, and GSBD

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Summary

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, SLRC, BCSF, and GSBD

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Do analysts rate CCAP or CGBD?

Is CCAP or CGBD more profitable?

Does the media prefer CCAP or CGBD?

Which has more risk & volatility, CCAP or CGBD?

Which has preferable earnings and valuation, CCAP or CGBD?

Do institutionals & insiders hold more shares of CCAP or CGBD?

Is CCAP or CGBD a better dividend stock?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Which has more volatility and risk, CCAP or MFIC?

Which has better earnings and valuation, CCAP or MFIC?

Do analysts prefer CCAP or MFIC?

Is CCAP or MFIC a better dividend stock?

Do institutionals and insiders believe in CCAP or MFIC?

Is CCAP or MFIC more profitable?

Does the media refer more to CCAP or MFIC?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Which has more volatility and risk, SLRC or CCAP?

Do analysts prefer SLRC or CCAP?

Is SLRC or CCAP a better dividend stock?

Do institutionals and insiders believe in SLRC or CCAP?

Which has higher earnings and valuation, SLRC or CCAP?

Is SLRC or CCAP more profitable?

Does the media prefer SLRC or CCAP?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Which has more volatility & risk, CCAP or BCSF?

Is CCAP or BCSF a better dividend stock?

Which has preferable earnings & valuation, CCAP or BCSF?

Does the media refer more to CCAP or BCSF?

Do analysts recommend CCAP or BCSF?

Do insiders and institutionals believe in CCAP or BCSF?

Is CCAP or BCSF more profitable?

Summary

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Is CCAP or GSBD more profitable?

Do institutionals & insiders believe in CCAP or GSBD?

Does the media favor CCAP or GSBD?

Which has more volatility and risk, CCAP or GSBD?

Is CCAP or GSBD a better dividend stock?

Which has preferable valuation & earnings, CCAP or GSBD?

Do analysts prefer CCAP or GSBD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools